Literature DB >> 22669479

Penumbra detection using PWI/DWI mismatch MRI in a rat stroke model with and without comorbidity: comparison of methods.

Emma Reid1, Delyth Graham, M Rosario Lopez-Gonzalez, William M Holmes, I Mhairi Macrae, Christopher McCabe.   

Abstract

Perfusion-diffusion (perfusion-weighted imaging (PWI)/diffusion-weighted imaging (DWI)) mismatch is used to identify penumbra in acute stroke. However, limitations in penumbra detection with mismatch are recognized, with a lack of consensus on thresholds, quantification and validation of mismatch. We determined perfusion and diffusion thresholds from final infarct in the clinically relevant spontaneously hypertensive stroke-prone (SHRSP) rat and its normotensive control strain, Wistar-Kyoto (WKY) and compared three methods for penumbra calculation. After permanent middle cerebral artery occlusion (MCAO) (WKY n=12, SHRSP n=15), diffusion-weighted (DWI) and perfusion-weighted (PWI) images were obtained for 4 hours post stroke and final infarct determined at 24 hours on T(2) scans. The PWI/DWI mismatch was calculated from volumetric assessment (perfusion deficit volume minus apparent diffusion coefficient (ADC)-defined lesion volume) or spatial assessment of mismatch area on each coronal slice. The ADC-derived lesion growth provided the third, retrospective measure of penumbra. At 1 hour after MCAO, volumetric mismatch detected smaller volumes of penumbra in both strains (SHRSP: 31 ± 50 mm(3), WKY: 22 ± 59 mm(3), mean ± s.d.) compared with spatial assessment (SHRSP: 36 ± 15 mm(3), WKY: 43 ± 43 mm(3)) and ADC lesion expansion (SHRSP: 41 ± 45 mm(3), WKY: 65 ± 41 mm(3)), although these differences were not statistically significant. Spatial assessment appears most informative, using both diffusion and perfusion data, eliminating the influence of negative mismatch and allowing the anatomical location of penumbra to be assessed at given time points after stroke.

Entities:  

Mesh:

Year:  2012        PMID: 22669479      PMCID: PMC3434632          DOI: 10.1038/jcbfm.2012.69

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  38 in total

1.  Refining the perfusion-diffusion mismatch hypothesis.

Authors:  K S Butcher; M Parsons; L MacGregor; P A Barber; J Chalk; C Bladin; C Levi; T Kimber; D Schultz; J Fink; B Tress; G Donnan; S Davis
Journal:  Stroke       Date:  2005-06       Impact factor: 7.914

2.  Relation of apparent diffusion coefficient changes and metabolic disturbances after 1 hour of focal cerebral ischemia and at different reperfusion phases in rats.

Authors:  L Olah; S Wecker; M Hoehn
Journal:  J Cereb Blood Flow Metab       Date:  2001-04       Impact factor: 6.200

3.  Characterization of the microglial response to cerebral ischemia in the stroke-prone spontaneously hypertensive rat.

Authors:  L Marks; H V Carswell; E E Peters; D I Graham; J Patterson; A F Dominiczak; I M Macrae
Journal:  Hypertension       Date:  2001-07       Impact factor: 10.190

4.  The CBF threshold and dynamics for focal cerebral infarction in spontaneously hypertensive rats.

Authors:  M Jacewicz; J Tanabe; W A Pulsinelli
Journal:  J Cereb Blood Flow Metab       Date:  1992-05       Impact factor: 6.200

5.  Impaired functional recovery after stroke in the stroke-prone spontaneously hypertensive rat.

Authors:  J K McGill; L Gallagher; H V O Carswell; E A Irving; A F Dominiczak; I M Macrae
Journal:  Stroke       Date:  2004-11-29       Impact factor: 7.914

6.  Delayed secondary phase of peri-infarct depolarizations after focal cerebral ischemia: relation to infarct growth and neuroprotection.

Authors:  Jed A Hartings; Michael L Rolli; X-C May Lu; Frank C Tortella
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

7.  Evolution of regional changes in apparent diffusion coefficient during focal ischemia of rat brain: the relationship of quantitative diffusion NMR imaging to reduction in cerebral blood flow and metabolic disturbances.

Authors:  M Hoehn-Berlage; D G Norris; K Kohno; G Mies; D Leibfritz; K A Hossmann
Journal:  J Cereb Blood Flow Metab       Date:  1995-11       Impact factor: 6.200

8.  Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats.

Authors:  Takuya Kishi; Yoshitaka Hirooka; Yoshikuni Kimura; Koji Ito; Hiroaki Shimokawa; Akira Takeshita
Journal:  Circulation       Date:  2004-04-26       Impact factor: 29.690

9.  Differential outcome to middle cerebral artery occlusion in spontaneously hypertensive stroke-prone rats (SHRSP) and Wistar Kyoto (WKY) rats.

Authors:  P Coyle; P T Jokelainen
Journal:  Stroke       Date:  1983 Jul-Aug       Impact factor: 7.914

10.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

View more
  23 in total

1.  Impact of stroke co-morbidities on cortical collateral flow following ischaemic stroke.

Authors:  Ifechukwude J Biose; Deborah Dewar; I Mhairi Macrae; Christopher McCabe
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-24       Impact factor: 6.200

2.  The effect of pyruvate on the development and progression of post-stroke depression: A new therapeutic approach.

Authors:  Dmitry Frank; Ruslan Kuts; Philip Tsenter; Benjamin F Gruenbaum; Yulia Grinshpun; Vladislav Zvenigorodsky; Ilan Shelef; Dmitry Natanel; Evgeny Brotfain; Alexander Zlotnik; Matthew Boyko
Journal:  Neuropharmacology       Date:  2019-05-31       Impact factor: 5.250

3.  Ischemic penumbra as a trigger for intracranial pressure rise - A potential cause for collateral failure and infarct progression?

Authors:  Daniel J Beard; Caitlin L Logan; Damian D McLeod; Rebecca J Hood; Debbie Pepperall; Lucy A Murtha; Neil J Spratt
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-12       Impact factor: 6.200

Review 4.  The importance of comorbidities in ischemic stroke: Impact of hypertension on the cerebral circulation.

Authors:  Marilyn J Cipolla; David S Liebeskind; Siu-Lung Chan
Journal:  J Cereb Blood Flow Metab       Date:  2018-09-10       Impact factor: 6.200

5.  MRI Guiding of the Middle Cerebral Artery Occlusion in Rats Aimed to Improve Stroke Modeling.

Authors:  Ilya L Gubskiy; Daria D Namestnikova; Elvira A Cherkashova; Vladimir P Chekhonin; Vladimir P Baklaushev; Leonid V Gubsky; Konstantin N Yarygin
Journal:  Transl Stroke Res       Date:  2017-11-25       Impact factor: 6.829

Review 6.  The Applicability of Amide Proton Transfer Imaging in the Nervous System: Focus on Hypoxic-Ischemic Encephalopathy in the Neonate.

Authors:  Yang Zheng; Xiaoming Wang
Journal:  Cell Mol Neurobiol       Date:  2017-09-23       Impact factor: 5.046

7.  A novel SPECT-based approach reveals early mechanisms of central and peripheral inflammation after cerebral ischemia.

Authors:  Krisztián Szigeti; Ildikó Horváth; Dániel S Veres; Bernadett Martinecz; Nikolett Lénárt; Noémi Kovács; Erika Bakcsa; Alexa Márta; Mariann Semjéni; Domokos Máthé; Ádám Dénes
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-29       Impact factor: 6.200

8.  Hyperglycemia accelerates apparent diffusion coefficient-defined lesion growth after focal cerebral ischemia in rats with and without features of metabolic syndrome.

Authors:  David Tarr; Delyth Graham; Lisa A Roy; William M Holmes; Christopher McCabe; I Mhairi Macrae; Keith W Muir; Deborah Dewar
Journal:  J Cereb Blood Flow Metab       Date:  2013-07-10       Impact factor: 6.200

9.  Dynamic perfusion and diffusion MRI of cortical spreading depolarization in photothrombotic ischemia.

Authors:  Yu-Chieh Jill Kao; Wenjing Li; Hsin-Yi Lai; Esteban A Oyarzabal; Weili Lin; Yen-Yu Ian Shih
Journal:  Neurobiol Dis       Date:  2014-07-25       Impact factor: 5.996

10.  The influence of gender on 'tissue at risk' in acute stroke: A diffusion-weighted magnetic resonance imaging study in a rat model of focal cerebral ischaemia.

Authors:  Tracey A Baskerville; I Mhairi Macrae; William M Holmes; Christopher McCabe
Journal:  J Cereb Blood Flow Metab       Date:  2015-09-30       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.